Galectin Therapeutics (GALT) Dividends payables (2010 - 2025)
Galectin Therapeutics' quarterly Dividends payables came in at $63000.0 in Q4 2025, little changed year-on-year from $63000.0 in Q4 2024, and little changed quarter-over-quarter from $63000.0 in Q2 2025.
Galectin Therapeutics has reported Dividends payables for 16 years, with the latest figure at $63000.0 in Q4 2025.
- For the quarter ending Q4 2025, Dividends payables changed 0.0% year-over-year to $63000.0; the trailing twelve-month figure through Dec 2025 stood at $63000.0 (changed 0.0% YoY), and the FY2025 full-year result was $63000.0, changed 0.0% from the prior year.
- Dividends payables for Q4 2025 stood at $63000.0, roughly flat from $63000.0 in the prior quarter.
- The five-year high for Dividends payables was $65000.0 in Q2 2021, with the low at $63000.0 in Q4 2023.
- Average Dividends payables over 5 years is $63700.0, with a median of $63500.0 recorded in 2022.
- Year-over-year, Dividends payables changed 0.0% in 2021 and fell 1.56% in 2023.
- Tracing GALT's Dividends payables over 5 years: stood at $65000.0 in 2021, then retreated by 1.54% to $64000.0 in 2022, then slipped by 1.56% to $63000.0 in 2023, then changed by 0.0% to $63000.0 in 2024, then changed by 0.0% to $63000.0 in 2025.
- The last three Dividends payables figures came in at $63000.0 (Q4 2025), $63000.0 (Q2 2025), and $63000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Dec 31, 2022 | 64,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Dec 31, 2020 | 65,000.00 |
| Jun 30, 2020 | 66,000.00 |
| Dec 31, 2019 | 66,000.00 |
| Jun 30, 2019 | 66,000.00 |
| Dec 31, 2018 | 299,000.00 |
| Jun 30, 2018 | 67,000.00 |
| Dec 31, 2017 | 68,000.00 |
| Jun 30, 2017 | 68,000.00 |
| Dec 31, 2016 | 68,000.00 |
| Jun 30, 2016 | 68,000.00 |
| Dec 31, 2015 | 67,000.00 |
| Jun 30, 2015 | 68,000.00 |
| Dec 31, 2014 | 68,000.00 |
| Jun 30, 2014 | 69,000.00 |
| Dec 31, 2013 | 73,000.00 |
| Jun 30, 2013 | 79,000.00 |
| Dec 31, 2012 | 80,000.00 |
| Jun 30, 2012 | 80,000.00 |
| Dec 31, 2011 | 80,000.00 |
| Jun 30, 2011 | 81,000.00 |
| Dec 31, 2010 | 48,000.00 |